Larvol Delta - ANVIL-Nivolumab-After-Surgery-and-Chemotherapy-in-Treating-Patients-With-Stage-IBIIIA-Nonsmall-Cell-Lung-Cancer-An-ALCHEMIST-Treatment-Trial

ABP 206 (nivolumab biosimilar) - Amgen

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Nivocad (nivolumab biosimilar) - Biocad

http://clinicaltrials.gov/ct2/show/NCT02595944

Sep 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next